Success Stories: Our Team Acquires NIW Approval for a Research Scientist from Nepal with 5 Major International Research Fundings

 

Client’s Testimonial:

“Thank you very much for the I-140 approval information. The service from Wegreened was fantastic and we appreciate all of your efforts to make this successful.”


On March 7th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Synthetic Chemistry (Approval Notice).


General Field: Synthetic Chemistry

Position at the Time of Case Filing: Research Scientist

Country of Origin: Nepal

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: March 7th, 2022

Processing Time: 9 months, 17 days


Case Summary:

A research scientist in the field of synthetic chemistry from Nepal proposed an endeavor to continue his research on developing new chemical reactions for shortening synthetic routes, improving molecular complexity, and reducing overall cost when developing drug therapies to treat cancer and other diseases. So, it was clear that his research was very important because it advances the development of vital new drugs. This is why when he approached us for his NIW (National Interest Waiver) case, our team quickly aided him in preparing his case proving that his work was in the national interest. This was made possible by adding the following information:

  • His work has resulted in 6 peer-reviewed journal articles (3 of them first-authored) and 1 international patent application.
  • These publications have been cited a total of 31 times, according to Google Scholar.
  • Evidence of his major international and national funding sources namely the National Institute of General Medical Sciences, the European Community’s Seventh Framework Program, the German Research Foundation, the National Institutes of Health, and the National Science Foundation.
  • His expert status in the field is further confirmed by his appointment as a referee for peer-reviewed journals and conferences. He has conducted reviews for highly acclaimed journals. Therefore, his role as a peer reviewer proves he is an authority in the field.
  • We also illustrated these facts through testimonials collected from 5 experts in the field who wrote letters of recommendation in his favor. One such testimonial is shown below:
“[The client] is working to actively combat cancer as a synthetic organic and medicinal chemist studying the structure-activity relationships of proteasome inhibitors, which are known for their anticancer effects. Specifically, [client’s] research on the synthesis and evaluation of proteasome inhibitors have expanded the field’s capability to use these materials for the production of more effective cancer pharmaceuticals. Given the broad significance of public health, [client’s] work is of immense value to millions of people worldwide.”

We are extremely happy that our team could help our client prove his research, which is relevant to the improvement of anticancer drugs, reducing the death rate and economic burden associated with cancer, and enhancing pharmaceuticals for the treatment of a variety of illnesses. Thus, when the approval for this case arrived from USCIS, our team rejoiced in the victory. We are glad to share in the success of our client, and we wish him the best.